Australia's Bio-Gene Technology rises on deal to launch Qcide in Japan
16/03/2026 24:07
** Shares of Australia's Bio-Gene Technology BGT.AX rises as much as 28.6% to A$0.04, its highest level since mid-November, 2025 ** Stock posts its biggest intraday pct gain since November 14, 2025 ** Insecticide products maker enters non-binding term sheet with Sumitomo Corporation (Sumitomo) and Nakashima Trading ** Term sheet to help launch BGT's Qcide in Japan for use against household nuisance insects ** Near 915,014 shares change hands, 6.8x the 30-day average volume ** Stock has risen 87% this year, including session moves (Reporting by Roshan Thomas in Bengaluru) ((Roshan.Thomas@thomsonreuters.com;))
Recent news on Bio-Gene Technology
See all newsBrief: Bio-Gene Technology Receives Total Placement Commitments Of A$2.78 Million
Australia's Bio-Gene Technology slips to 4-1/2-month low on discounted placement
Brief: Bio-Gene Technology Ltd Raises A$3.21 MLN Via Placement, Partially Underwritten Share Purchase Plan
Brief: Bio-Gene Technology Seeks Trading Halt
Australia's Bio‑Gene surges on Asia expansion optimism for mosquito control products